The Russian vaccine developed against the new coronavirus – Sputnik V – is 95 percent effective, according to a second interim analysis of clinical trial data.
The Russian Ministry of Health reports that the results were obtained from volunteers 42 days after the injection of the first dose. The effectiveness after 28 days is 91.4%.
The vaccine, developed by the National Center for Epidemiology and Microbiology Gamaleya, in Moscow, is expected to be around eight euros per dose.
– .
Related posts:
Russians give troops rest, but bombs continue to fall in Ukraine
What if it turns out that Pepe doesn't come from San José?
Pemex reports financial and productive strength after reducing its debt by 25%
A Midi Fair to save a season of “rotten weather”: “as soon as there is a ray of sunshine, people com...
